Meta-Analysis of Visual Evoked Potential and Parkinson’s Disease

Background. Previous studies suggested that visual evoked potential (VEP) was impaired in patients with Parkinson’s disease (PD), but the results were inconsistent. Methods. We conducted a systematic review and meta-analysis to explore whether the VEP was significantly different between PD patients...

Full description

Saved in:
Bibliographic Details
Main Authors: Song-bin He, Chun-yan Liu, Lin-di Chen, Zhi-nan Ye, Ya-ping Zhang, Wei-guo Tang, Bin-da Wang, Xiang Gao
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Parkinson's Disease
Online Access:http://dx.doi.org/10.1155/2018/3201308
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550645853323264
author Song-bin He
Chun-yan Liu
Lin-di Chen
Zhi-nan Ye
Ya-ping Zhang
Wei-guo Tang
Bin-da Wang
Xiang Gao
author_facet Song-bin He
Chun-yan Liu
Lin-di Chen
Zhi-nan Ye
Ya-ping Zhang
Wei-guo Tang
Bin-da Wang
Xiang Gao
author_sort Song-bin He
collection DOAJ
description Background. Previous studies suggested that visual evoked potential (VEP) was impaired in patients with Parkinson’s disease (PD), but the results were inconsistent. Methods. We conducted a systematic review and meta-analysis to explore whether the VEP was significantly different between PD patients and healthy controls. Case-control studies of PD were selected through an electronic search of the databases PubMed, Embase, and the Cochrane Central Register of Controlled Trials. We calculated the pooled weighted mean differences (WMDs) and 95% confidence intervals (CIs) between individuals with PD and controls using the random-effects model. Results. Twenty case-control studies which met our inclusion criteria were included in the final meta-analysis. We found that the P100 latency in PD was significantly higher compared with healthy controls (pooled WMD = 6.04, 95% CI: 2.73 to 9.35, P=0.0003, n=20). However, the difference in the mean amplitude of P100 was not significant between the two groups (pooled WMD = 0.64, 95% CI: −0.06 to 1.33, P=0.07) based on 10 studies with the P100 amplitude values available. Conclusions. The higher P100 latency of VEP was observed in PD patients, relative to healthy controls. Our findings suggest that electrophysiological changes and functional defect in the visual pathway of PD patients are important to our understanding of the pathophysiology of visual involvement in PD.
format Article
id doaj-art-9fd6053db32c4496b34b18661896c945
institution Kabale University
issn 2090-8083
2042-0080
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Parkinson's Disease
spelling doaj-art-9fd6053db32c4496b34b18661896c9452025-02-03T06:06:11ZengWileyParkinson's Disease2090-80832042-00802018-01-01201810.1155/2018/32013083201308Meta-Analysis of Visual Evoked Potential and Parkinson’s DiseaseSong-bin He0Chun-yan Liu1Lin-di Chen2Zhi-nan Ye3Ya-ping Zhang4Wei-guo Tang5Bin-da Wang6Xiang Gao7Department of Neurology, Zhoushan Hospital, Wenzhou Medical University, Zhoushan 316021, ChinaDepartment of Critical Care Medicine, Huzhou Central Hospital, Huzhou 313000, ChinaDepartment of Neurology, Zhoushan Hospital, Wenzhou Medical University, Zhoushan 316021, ChinaDepartment of Neurology, Taizhou Municipal Hospital, Taizhou 318000, ChinaDepartment of Neurology, Taizhou Municipal Hospital, Taizhou 318000, ChinaDepartment of Neurology, Zhoushan Hospital, Wenzhou Medical University, Zhoushan 316021, ChinaDepartment of Neurology, Zhoushan Hospital, Wenzhou Medical University, Zhoushan 316021, ChinaDepartment of Nutritional Sciences, The Pennsylvania State University, USABackground. Previous studies suggested that visual evoked potential (VEP) was impaired in patients with Parkinson’s disease (PD), but the results were inconsistent. Methods. We conducted a systematic review and meta-analysis to explore whether the VEP was significantly different between PD patients and healthy controls. Case-control studies of PD were selected through an electronic search of the databases PubMed, Embase, and the Cochrane Central Register of Controlled Trials. We calculated the pooled weighted mean differences (WMDs) and 95% confidence intervals (CIs) between individuals with PD and controls using the random-effects model. Results. Twenty case-control studies which met our inclusion criteria were included in the final meta-analysis. We found that the P100 latency in PD was significantly higher compared with healthy controls (pooled WMD = 6.04, 95% CI: 2.73 to 9.35, P=0.0003, n=20). However, the difference in the mean amplitude of P100 was not significant between the two groups (pooled WMD = 0.64, 95% CI: −0.06 to 1.33, P=0.07) based on 10 studies with the P100 amplitude values available. Conclusions. The higher P100 latency of VEP was observed in PD patients, relative to healthy controls. Our findings suggest that electrophysiological changes and functional defect in the visual pathway of PD patients are important to our understanding of the pathophysiology of visual involvement in PD.http://dx.doi.org/10.1155/2018/3201308
spellingShingle Song-bin He
Chun-yan Liu
Lin-di Chen
Zhi-nan Ye
Ya-ping Zhang
Wei-guo Tang
Bin-da Wang
Xiang Gao
Meta-Analysis of Visual Evoked Potential and Parkinson’s Disease
Parkinson's Disease
title Meta-Analysis of Visual Evoked Potential and Parkinson’s Disease
title_full Meta-Analysis of Visual Evoked Potential and Parkinson’s Disease
title_fullStr Meta-Analysis of Visual Evoked Potential and Parkinson’s Disease
title_full_unstemmed Meta-Analysis of Visual Evoked Potential and Parkinson’s Disease
title_short Meta-Analysis of Visual Evoked Potential and Parkinson’s Disease
title_sort meta analysis of visual evoked potential and parkinson s disease
url http://dx.doi.org/10.1155/2018/3201308
work_keys_str_mv AT songbinhe metaanalysisofvisualevokedpotentialandparkinsonsdisease
AT chunyanliu metaanalysisofvisualevokedpotentialandparkinsonsdisease
AT lindichen metaanalysisofvisualevokedpotentialandparkinsonsdisease
AT zhinanye metaanalysisofvisualevokedpotentialandparkinsonsdisease
AT yapingzhang metaanalysisofvisualevokedpotentialandparkinsonsdisease
AT weiguotang metaanalysisofvisualevokedpotentialandparkinsonsdisease
AT bindawang metaanalysisofvisualevokedpotentialandparkinsonsdisease
AT xianggao metaanalysisofvisualevokedpotentialandparkinsonsdisease